نتایج جستجو برای: beta interferon therapy

تعداد نتایج: 880725  

Journal: :hepatitis monthly 0
ligita jancoriene department of infectious, chest diseases, dermatovenerology and alergology, faculty of medicine, vilnius university, vilnius, lithuania; department of infectious, chest diseases, dermatovenerology and alergology, faculty of medicine, vilnius university, vilnius, lithuania. tel: +37-68785870, fax: +37-52752790 dovile norvydaite department of otolaryngology and eye diseases, faculty of medicine, vilnius university, vilnius, lithuania saulius galgauskas department of otolaryngology and eye diseases, faculty of medicine, vilnius university, vilnius, lithuania evelina balciunaite department of xx, faculty of medicine, vilnius university, vilnius, lithuania

introduction patients with hepatitis c are commonly treated with combination of pegylated interferon alfa-2a and ribavirin. less than 1% of patients receiving this treatment experience very uncommon ophthalmological side effects such as optic neuropathy and vision disorder, which are usually subclinical, mild and reversible, not requiring the withdrawal of the treatment. retinopathy is the most...

Journal: :Molecular therapy : the journal of the American Society of Gene Therapy 2006
Ritika Jaini Drew Hannaman Justin M Johnson Robert M Bernard Cengiz Z Altuntas Maida M Delasalas Pavani Kesaraju Alain Luxembourg Claire F Evans Vincent K Tuohy

In contrast to serial injections of recombinant interferon-beta (IFN-beta) for long-term therapy of multiple sclerosis (MS), prolonged systemic delivery of proteins derived through in vivo gene transfer may provide a more clinically relevant alternative. Here we compare the therapeutic efficacies of electroporation (EP)-mediated intramuscular IFN-beta gene transfer with repeated alternate-day i...

Journal: :Frontiers in bioscience : a journal and virtual library 2004
James Ahn Xuan Feng Nilesh Patel Neetu Dhawan A T Reder

Interferon-gamma is produced by immune cells before MS exacerbations, and exogenous IFN-gamma treatment causes MS attacks. IFN-beta production, conversely, rises after exacerbations. IFN-beta therapy ameliorates MS, possibly by lowering IFN-gamma secretion and inhibiting responses to IFN-gamma. IFN-gamma effects are regulated by IFN-gamma receptor (IFNGR) expression. IFN-gamma is pro-inflammato...

2012
Davi Tanajura Costa Michael Sundberg Lúcia Passos André Luiz Muniz Silvane Santos

The human T-cell lymphotropic virus type 1 (HTLV-1) is the known causative agent of a chronic neurologic condition known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Although several therapies have been evaluated for HAM/TSP, none have been approved for use in humans. In this paper, we describe a 55-year-old female patient with HAM/TSP who was treated with interferon ...

Journal: :hepatitis monthly 0
reza karbasi-afshar cardiovascular diseases department, baqiyatallah university of medical sciences, tehran, ir iran amin saburi chemical injuries research center, baqiyatallah university of medical sciences, tehran, ir iran; baqiyatallah research center of gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran; chemical injuries research center and baqiyatallah research center of gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, mollasadra st, vanaksq, tehran, ir iran. tel/fax: +98-2188600067

Journal: :The New England journal of medicine 2008
Alasdair J Coles D Alastair S Compston Krzysztof W Selmaj Stephen L Lake Susan Moran David H Margolin Kim Norris P K Tandon

BACKGROUND Alemtuzumab, a humanized monoclonal antibody that targets CD52 on lymphocytes and monocytes, may be an effective treatment for early multiple sclerosis. METHODS In this phase 2, randomized, blinded trial involving previously untreated, early, relapsing-remitting multiple sclerosis, we assigned 334 patients with scores of 3.0 or less on the Expanded Disability Status Scale and a dis...

Journal: :hepatitis monthly 0
imran tipu institute of biochemistry and biotechnology, university of the punjab, lahore, pakistan; manchester institute of biotechnology, university of manchester, manchester, uk; institute of biochemistry and biotechnology, university of the punjab, lahore, pakistan. tel: +92-3214029804 fiona marriage manchester institute of biotechnology, university of manchester, manchester, uk; centre for integrated genomic medical research, university of manchester, manchester, uk zia-ur-rahman farooqi manchester institute of biotechnology, university of manchester, manchester, uk; national university of science and technology, islamabad, pakistan hazel platt centre for integrated genomic medical research, university of manchester, manchester, uk muhammad amin athar institute of biochemistry and biotechnology, university of the punjab, lahore, pakistan philip john day manchester institute of biotechnology, university of manchester, manchester, uk; centre for integrated genomic medical research, university of manchester, manchester, uk

background polymorphisms in the interferon λ (inf λ) genes on chromosome 19 have been associated with clearance of hepatitis c virus (hcv) induced by interferon and ribavirin therapy however there is no such data available for pakistani patients with hcv infection. objectives in this study, the effects of single nucleotide polymorphisms (snps) have been investigated in response to treatment wit...

Journal: :Archives of neurology 2005
Bruce A C Cree Ahmad Al-Sabbagh Randy Bennett Douglas Goodin

BACKGROUND African Americans (AAs) with multiple sclerosis (MS) seem to have a more severe disease course than white Americans (WAs). To our knowledge, it is not known to what extent treatment with interferon beta-1a will effect the MS disease course within the AA population. OBJECTIVE To compare the response to treatment with interferon beta-1a between AA and WA MS patients. DESIGN This is...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید